Our findings demonstrate that CANA inhibits cell proliferation and EMT in CCA cell lines; however, the activation of SIRT1 by CANA through the NAD+ salvage pathway can promote the proliferation of CCA cells. The gene discussed is SIRT1; the disease is cholangiocarcinoma.